Health insurance affects the use of disease-modifying therapy in multiple sclerosis.

ABSTRACT:

Objective

To evaluate the association between health insurance coverage and disease-modifying therapy (DMT) use for multiple sclerosis (MS).

Methods

In 2014, we surveyed participants in the North American Research Committee on MS registry regarding health insurance coverage. We investigated associations between negative insurance change and (1) the type of insurance, (2) DMT use, (3) use of free/discounted drug programs, and (4) insurance challenges using multivariable logistic regressions.

Results

Of 6,662 respondents included in the analysis, 6,562 (98.5%) had health insurance, but 1,472 (22.1%) reported negative insurance change compared with 12 months earlier. Respondents with private insurance were more likely to report negative insurance change than any other in

SUBMITTER: Wang G 

PROVIDER: S-EPMC4977112 | biostudies-literature | 2016 Jul

REPOSITORIES: biostudies-literature